Submission Details
| 510(k) Number | K191172 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 01, 2019 |
| Decision Date | June 20, 2019 |
| Days to Decision | 50 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
K191172 is an FDA 510(k) clearance for the Cepheid Xpert MRSA NxG Control Panel, a Assayed External Control Material For Microbiology Nucleic Acid Amplification (nat) Assays (Class II — Special Controls, product code PMN), submitted by Microbiologics, Inc. (St. Cloud, US). The FDA issued a Cleared decision on June 20, 2019, 50 days after receiving the submission on May 1, 2019. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3920.
| 510(k) Number | K191172 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 01, 2019 |
| Decision Date | June 20, 2019 |
| Days to Decision | 50 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | PMN — Assayed External Control Material For Microbiology Nucleic Acid Amplification (nat) Assays |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.3920 |
| Definition | Assayed External Quality Control Material To Monitor The Performance Of Microbiology Nucleic Acid Assays For In Vitro Diagnostic Use. |